About this ETF
The Innovator U.S. Small Cap Managed 10 Buffer ETF is an actively managed fund, administered by Parametric, that aims to give investors exposure to smaller U.S. companies. Its structure is designed to temper market swings and provide a degree of downside protection, specifically targeting a buffer against the first 10% to 14% of losses experienced by its underlying benchmark.
Description from the fund data provider · profile as of Aug 27, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +1.97% | +6.88% | +10.77% | — | — | — | — | — | +11.08% |
| Total return | +1.99% | +7.10% | +11.09% | — | — | — | — | — | +11.41% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 26, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.79% | Annual cost of a $10,000 investment | $79.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Aug 22, 2026 — portfolio reporting date from the data provider; holdings are not live positions. 843 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | US BANK MMDA - USBGFS 9 09/01/2037 | — | 3.79% | 422.15K | $422.1K |
| 2 | IWM 06/30/2027 300 P | — | 1.60% | 92 | $178.4K |
| 3 | IWM 03/31/2027 247 P | — | 0.35% | 92 | $39.3K |
| 4 | Twist Bioscience Corp | TWST | 0.33% | 256 | $37.3K |
| 5 | Protagonist Therapeutics Inc | PTGX | 0.33% | 240 | $37.0K |
| 6 | JFrog Ltd | FROG | 0.33% | 400 | $36.9K |
| 7 | 10X Genomics Inc | TXG | 0.31% | 528 | $34.4K |
| 8 | Spyre Therapeutics Inc | SYRE | 0.31% | 320 | $34.1K |
| 9 | PBF Energy Inc | PBF | 0.29% | 440 | $32.4K |
| 10 | Oruka Therapeutics Inc | ORKA | 0.29% | 296 | $32.0K |
| 11 | Merit Medical Systems Inc | MMSI | 0.28% | 344 | $31.2K |
| 12 | TG Therapeutics Inc | TGTX | 0.27% | 560 | $30.4K |
| 13 | IWM 12/31/2026 260 P | — | 0.27% | 91 | $30.4K |
| 14 | Oscar Health Inc | OSCR | 0.27% | 946 | $30.3K |
| 15 | SM Energy Co | SM | 0.27% | 812 | $30.2K |
| 16 | Apogee Therapeutics Inc | APGE | 0.27% | 224 | $30.2K |
| 17 | Avnet Inc | AVT | 0.27% | 340 | $30.1K |
| 18 | elf Beauty Inc | ELF | 0.25% | 273 | $27.8K |
| 19 | Definium Therapeutics Inc | DFTX | 0.25% | 608 | $27.3K |
| 20 | Matson Inc | MATX | 0.24% | 120 | $26.7K |
| 21 | Amylyx Pharmaceuticals Inc | AMLX | 0.24% | 680 | $26.3K |
| 22 | Madison Square Garden Sports Corp | MSGS | 0.23% | 64 | $26.0K |
| 23 | H&R Block Inc | HRB | 0.23% | 484 | $26.0K |
| 24 | GATX Corp | GATX | 0.23% | 145 | $25.7K |
| 25 | Victoria's Secret & Co | VSXY | 0.23% | 299 | $25.5K |
Click a ticker to see every ETF that owns it.
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 0.29% | Paid (last 12 months) | $0.0810 |
| Frequency | Quarterly | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Jun 30, 2026 | Last payment | $0.0520 (Jul 01, 2026) |
| Growth 1Y | — | Growth 3Y / 5Y (ann.) | — / — |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Jun 30, 2026 | Jun 30, 2026 | Jul 01, 2026 | $0.0520 |
| Mar 31, 2026 | Mar 31, 2026 | Apr 01, 2026 | $0.0290 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
Liquidity
| Volume today | 5.49K | Average volume | 4.76K |
| AUM | $11.1M | Premium/Discount | -0.01% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | $26.8K | +0.24% | $11.1M → $11.1M |
| 1 Week | -$55.1K | -0.50% | $11.1M → $11.1M |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for KBFR
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.
KBFR